SNN Sunniva Inc

Sunniva Inc. Announces Resignation of President of Natural Health Services Ltd.

Sunniva Inc. Announces Resignation of President of Natural Health Services Ltd.

VANCOUVER, British Columbia, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Sunniva Inc. (“Sunniva”, the “Company”, “we”, “our” or “us”) (CSE:SNN) (OTCQB:SNNVF), a North American provider of cannabis products and services, announces that Daniel Vass has tendered his resignation as President of Natural Health Services Ltd. (“NHS”), a wholly owned subsidiary of the Company, effective immediately.

Mr. Vass also resigned as director of the Company effective immediately.

Dr. Anthony Holler, Chairman and CEO, commented: "We thank Dan for his contribution to the Company over the past two years and wish him well in his future endeavors.  The Company will ensure that the necessary plans are put in place to effect a smooth transition."

In order to ensure continuity going forward, Dr. Mark Kimmins, Medical Director of NHS, will take over day to day management of NHS in the interim. The Company will begin a search for a replacement and no changes in its goals or objectives are planned in the short term.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

About Sunniva Inc.

Sunniva, through its subsidiaries, is a vertically integrated cannabis company operating in the world’s two largest cannabis markets – Canada and California.  Our ability to leverage our large-scale, purpose-built cGMP designed greenhouses, offering better quality assurance with cannabis products free from pesticides, uniquely positions Sunniva as a leading supplier of safe, high quality products at scale. Through our strategically positioned cultivation and extraction facilities, we are launching Sunniva branded products in various product categories including flower, pre-rolls, beverages, vape cartridges, extracts as well as aggressively pursuing upstream vertical opportunities including distribution and retail expansion. Sunniva's management and board of directors have a proven track record for creating significant shareholder value both in the healthcare and biotech industries.

About Natural Health Services Ltd. (“NHS”)

NHS owns and operates a network of seven clinics in Canada specializing in medical cannabis under the Cannabis Act (Canada).  NHS connects patients with safe and effective medical cannabis products through Licenced Producers. NHS has in-house physicians and nurse practitioners specializing in the endocannabinoid system providing expert consultation, education, and recommendations for patients. NHS’ proprietary technology infrastructure assists physicians, patients and LPs to comply with the rules of Health Canada.  NHS currently has approximately 105,000 registered patients.

Company Contact:

Dr. Anthony Holler

Chairman and Chief Executive Officer

Phone: (866) 786-6482

Investor Contact:                                                            

Phil Carlson / Erika Kay                                                  

KCSA Strategic Communications                                               

Phone: (212) 896-1233                                                   

Email:  /                             

Media Contact:

Katelyn Tumino

KCSA Strategic Communications

Phone: (212) 896-1252

Email:    

EN
10/12/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Sunniva Inc

 PRESS RELEASE

Sunniva Inc. Announces Issuance of Secured Promissory Notes of its Who...

Sunniva Inc. Announces Issuance of Secured Promissory Notes of its Wholly-Owned Subsidiary, CP Logistics, LLC VANCOUVER, British Columbia, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Sunniva Inc. (“Sunniva”, the “Company”) (CSE:SNN) (OTC Pink Sheets:SNNVF) announced today that its wholly-owned subsidiary, CP Logistics, LLC (“CPL”), closed a non-brokered private placement of secured promissory notes (the “Notes”) on February 10, 2022, for aggregate proceeds of US$700,000. The Notes bear interest at a rate of 20% per annum, mature on January 31, 2026, and are secured against all of the assets of CPL....

 PRESS RELEASE

Sunniva Inc. Announces Financial Update

Sunniva Inc. Announces Financial Update  VANCOUVER, British Columbia, Jan. 14, 2022 (GLOBE NEWSWIRE) -- Sunniva Inc. (“Sunniva”, the “Company”) (CSE:SNN) (OTC Pink Sheets:SNNVF) provides an update on several financing related items. The Company’s wholly-owned subsidiary, CP Logistics, LLC (“CPL”), is proposing to conduct a non-brokered private placement of up to US$1M of secured promissory notes (the “Notes”), bearing interest at a rate of 20% per annum and maturing on January 31, 2026 (the “CPL Financing”). The Notes will be secured against all of the assets of CPL. If the Arbitration (...

 PRESS RELEASE

Sunniva Announces Update on Audit and Arbitration Matters

Sunniva Announces Update on Audit and Arbitration Matters VANCOUVER, British Columbia, Sept. 13, 2021 (GLOBE NEWSWIRE) -- Sunniva Inc. (“Sunniva”, the “Company”) (CSE:SNN) (OTC Pink Sheets:SNNVF) announces an update regarding work on the audits of the Company’s financial statements for the years ended December 31, 2019 and 2020.     After implementation of its Amended and Consolidated Plan of Compromise and Arrangement and its release and discharge from its CCAA proceedings, the Company engaged MNP LLP (“MNP”), its historical auditor, to conduct financial statement audits for the years e...

1 director sold

A director at Sunniva Inc sold 792,100 shares at 2.650CAD and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...

 PRESS RELEASE

Sunniva Estimates Over USD $55 Million Revenue in 2019 From Sunniva Br...

Sunniva Estimates Over USD $55 Million Revenue in 2019 From Sunniva Branded Products in California and Secures Additional USD $4.0 Million in Purchase Orders VANCOUVER, British Columbia, Feb. 14, 2019 (GLOBE NEWSWIRE) -- Sunniva Inc. (“Sunniva”, the “Company”, “we”, “our” or “us”) (CSE:SNN) (OTCQB:SNNVF), a North American provider of cannabis products and services, is pleased to announce that they have secured an additional USD $4.0 million in purchase orders from select retail dispensaries in southern California for Sunniva branded cannabis products. This increases the total sales orders...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch